Cargando…

Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’

Detalles Bibliográficos
Autores principales:	Napp, L. Christian, Jabs, Olga, Höckelmann, Anna, Dutzmann, Jochen, Kapopara, Piyushkumar R., Sedding, Daniel G., Gaestel, Matthias, Bauersachs, Johann, Bavendiek, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307761/ https://www.ncbi.nlm.nih.gov/pubmed/28228935 http://dx.doi.org/10.1186/s13221-016-0039-1

Ejemplares similares

Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice
por: Napp, L. Christian, et al.
Publicado: (2016)

MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis
por: Limbourg, Anne, et al.
Publicado: (2015)

Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Deficiency Reduces Insulin Sensitivity in High-Fat Diet-Fed Mice
por: de Boer, Jan Freark, et al.
Publicado: (2014)

Crucial Roles of the Protein Kinases MK2 and MK3 in a Mouse Model of Glomerulonephritis
por: Guess, Adam J., et al.
Publicado: (2013)

MAPKAP kinase 2 (MK2)-dependent and independent models of blister formation in pemphigus vulgaris
por: Mao, Xuming, et al.
Publicado: (2013)

Erratum: Nanoelectronic primary thermometry below 4 mK
por: Bradley, D. I., et al.
Publicado: (2016)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations
por: Herbert, Bethany A., et al.
Publicado: (2015)

Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Eskiocak, Ugur, et al.
Publicado: (2016)

Erratum to: PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells
por: Qi, Lei, et al.
Publicado: (2015)

IL‐33 regulates cytokine production and neutrophil recruitment via the p38 MAPK‐activated kinases MK2/3
por: McCarthy, Pierre C, et al.
Publicado: (2018)

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2016)

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease
por: Sedding, Daniel G., et al.
Publicado: (2018)

Erratum: Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation
por: Liu, Chengcheng, et al.
Publicado: (2017)

Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism
por: Chen, Yunliang, et al.
Publicado: (2015)

Cooperative and distinct functions of MK2 and MK3 in the regulation of the macrophage transcriptional response to lipopolysaccharide
por: Ehlting, Christian, et al.
Publicado: (2019)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients with Advanced Renal Cell Carcinoma: Erratum
Publicado: (2014)

Erratum to: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
por: Russo, Isabella, et al.
Publicado: (2016)

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
por: Dutzmann, Jochen, et al.
Publicado: (2017)

Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
por: Phillip, Cornel Joseph, et al.
Publicado: (2016)

ERRATUM 2
Publicado: (2010)

MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination
por: Tietz, Silvia M., et al.
Publicado: (2014)

Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK
por: Ronkina, Natalia, et al.
Publicado: (2015)

Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
por: Saleem, Azeem, et al.
Publicado: (2017)

Erratum to: AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
por: Tandelilin, Andreas A. K., et al.
Publicado: (2015)

Identification of Normal Blood Pressure in Different Age Group: Erratum
Publicado: (2016)

Identification of Normal Blood Pressure in Different Age Group: Erratum
Publicado: (2018)

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2017)

Erratum: Noncanonical cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1
por: Mihaly, September R., et al.
Publicado: (2017)

Erratum: Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling
por: Avanzato, D., et al.
Publicado: (2016)

The p38/MK2 Axis in Monocytes of Fibromyalgia Syndrome Patients: An Explorative Study
por: Nugraha, Boya, et al.
Publicado: (2021)

Erratum: Vol. 14, No. 2
Publicado: (2008)

Erratum—Vol. 15, No. 2
Publicado: (2009)

Erratum: Vol. 71, No. 2
Publicado: (2022)

Erratum: Vol. 72, No. 2
Publicado: (2023)

Erratum: N-myc Downstream-Regulated Gene 2 (NDRG2) Promotes Bone Morphogenetic Protein 2 (BMP2)-Induced Osteoblastic Differentiation and Calcification by Janus Kinase 3 (JAK3)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
por: Chen, SunYu, et al.
Publicado: (2021)

Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
por: Allegretti, Matteo, et al.
Publicado: (2016)

Erratum to "LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells" by Guo Z, et al. (Yonsei Med J 2014;55:1196-205.)
Publicado: (2014)

Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jf1ujb15cbcmbpp8mm1vbura5p